Sign up to save your podcasts
Or
Share The Verdict on AI Scribes - Analysing their First Major RCTs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Verdict on AI Scribes - Analysing their First Major RCTs
Everyone is talking about ambient AI scribes, but until now, we’ve relied on marketing hype and small pilots. This week, we dive into two landmark Randomized Controlled Trials published in NEJM AI featuring Abridge, DAX Copilot, and Nabla. The results? Complicated. We explore why these tools might be solving burnout without actually saving time, the hidden "measurement trap" in electronic health records, and why the real revolution isn't about writing notes—it’s about what happens next.
References:
The Editorial: AI Scribes Are Not Productivity Tools (Yet)
Authors: Eileen Kim, Vincent X. Liu, and Karandeep Singh
NEJM AI. 2025;2(12).
DOI: 10.1056/AIe2501051
The UCLA Study (Comparing DAX Copilot, Nabla, and Control): Ambient AI Scribes in Clinical Practice: A Randomized Trial
Authors: Paul J. Lukac, William Turner, Sitaram Vangala, Aaron T. Chin, Joshua Khalili, Ya-Chen Tina Shih, Catherine Sarkisian, Eric M. Cheng, and John N. Mafi
NEJM AI. 2025;2(12).
DOI: 10.1056/AIoa2501000
The UW Health Study (Testing Abridge): A Pragmatic Randomized Controlled Trial of Ambient Artificial Intelligence to Improve Health Practitioner Well-Being
Authors: Majid Afshar, Mary Ryan Baumann, Felice Resnik, Josie Hintzke, Anne Gravel Sullivan, Graham Wills, Kayla Lemmon, Jason Dambach, Leigh Ann Mrotek, Mariah Quinn, Kirsten Abramson, Peter Kleinschmidt, Thomas B. Brazelton, Margaret A. Leaf, Heidi Twedt, David Kunstman, Brian Patterson, Frank Liao, Stacy Rasmussen, Elizabeth S. Burnside, Cherodeep Goswami, and Joel Gordon
NEJM AI. 2025;2(12).
DOI: 10.1056/AIoa2500945
#HealthAI #DigitalHealth #ClinicianBurnout #MedTech #NEJMAI #AmbientScribes #NHS #HealthcareInnovation #ai in medicine Music generated by Mubert https://mubert.com/render
View all episodes
By Stephen AugerEveryone is talking about ambient AI scribes, but until now, we’ve relied on marketing hype and small pilots. This week, we dive into two landmark Randomized Controlled Trials published in NEJM AI featuring Abridge, DAX Copilot, and Nabla. The results? Complicated. We explore why these tools might be solving burnout without actually saving time, the hidden "measurement trap" in electronic health records, and why the real revolution isn't about writing notes—it’s about what happens next.
References:
The Editorial: AI Scribes Are Not Productivity Tools (Yet)
Authors: Eileen Kim, Vincent X. Liu, and Karandeep Singh
NEJM AI. 2025;2(12).
DOI: 10.1056/AIe2501051
The UCLA Study (Comparing DAX Copilot, Nabla, and Control): Ambient AI Scribes in Clinical Practice: A Randomized Trial
Authors: Paul J. Lukac, William Turner, Sitaram Vangala, Aaron T. Chin, Joshua Khalili, Ya-Chen Tina Shih, Catherine Sarkisian, Eric M. Cheng, and John N. Mafi
NEJM AI. 2025;2(12).
DOI: 10.1056/AIoa2501000
The UW Health Study (Testing Abridge): A Pragmatic Randomized Controlled Trial of Ambient Artificial Intelligence to Improve Health Practitioner Well-Being
Authors: Majid Afshar, Mary Ryan Baumann, Felice Resnik, Josie Hintzke, Anne Gravel Sullivan, Graham Wills, Kayla Lemmon, Jason Dambach, Leigh Ann Mrotek, Mariah Quinn, Kirsten Abramson, Peter Kleinschmidt, Thomas B. Brazelton, Margaret A. Leaf, Heidi Twedt, David Kunstman, Brian Patterson, Frank Liao, Stacy Rasmussen, Elizabeth S. Burnside, Cherodeep Goswami, and Joel Gordon
NEJM AI. 2025;2(12).
DOI: 10.1056/AIoa2500945
#HealthAI #DigitalHealth #ClinicianBurnout #MedTech #NEJMAI #AmbientScribes #NHS #HealthcareInnovation #ai in medicine Music generated by Mubert https://mubert.com/render